文献速递血栓与止血

重新分类血友病以纳入结局定义和表型作为新目标

Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets.
PubMed 文献 · J Thromb Haemost · 2023-03-25

血友病按凝血因子活性水平分为轻型、中型和重型,凝血因子替代与预防方案有助于减少出血及相关并发症。随着多种新疗法已获批或即将获批,在预防出血之外还需考虑健康相关生活质量作为综合照护目标,作者因此呼吁国际血栓与止血学会重新审视现行血友病分类。

要点

  • 现行血友病分类基于凝血因子活性水平,分为轻型、中型和重型。
  • 凝血因子替代与预防方案有助于减少出血及其相关并发症。
  • 作者呼吁国际血栓与止血学会重新审视现行血友病分类。

核心结论

  • 随着多种新疗法已获批或即将获批,除预防出血外还需考虑健康相关生活质量作为血友病综合照护目标,作者呼吁国际血栓与止血学会重新审视现行血友病分类。

研究设计与样本

  • 本文为论述性文章,讨论将结局定义和表型纳入血友病分类的理由。

主要发现

  • 血友病按凝血因子活性水平分为轻型、中型和重型。
  • 凝血因子替代与预防方案有助于减少出血及其相关并发症。
  • 部分新疗法已获批,另有一些即将获批。

临床怎么用

  • 作者呼吁国际血栓与止血学会重新审视现行血友病分类,以将结局定义和表型纳入新目标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hemophilia is classified into mild, moderate, and severe based on coagulation factor activity levels. Factor replacement and prophylaxis regimens in persons with hemophilia have helped to reduce bleeding and its related complications. With several newer treatments, some already approved and others soon to be, there may be a need to consider health-related quality of life in addition to bleed prevention as the goals of providing comprehensive care to persons with hemophilia. In this article, we discussed the reasons why such an approach may be relevant and call for the International Society of Thrombosis and Haemostasis to revisit the current classification of hemophilia.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Thachil J, Connors JM, Mahlangu J, et al. Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets. J Thromb Haemost. 2023. PMID: 36972786. doi:10.1016/j.jtha.2023.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。